Passage BIO, Inc.
Biological Products, (No Diagnostic Substances) · Philadelphia, PA, United States
- PrincipalsKathleen BorthwickCFOWilliam ChouPRESIDENT AND CEO
- CompanyPassage BIO, Inc.Philadelphia, PA, United States
- Phone line+1 (267) 866-0312General business
Passage BIO, Inc. is an SEC-registered Nasdaq-listed company (ticker PASG) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 2
Chief executive
William ChouPRESIDENT AND CEO
Finance
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Kathleen Borthwick — CFO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗William Chou — PRESIDENT AND CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Pluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityKiniksa Pharmaceuticals International, plcPharmaceutical Preparations · London1 shared capability